U.S. scientists will begin large-scale Ebola vaccine tests in West Africa within the next few weeks, officials announced Thursday.
The National Institutes of Health is launching a clinical trial of two different vaccines in partnership with the Liberian government, USA Today reports. In Sierra Leone, the Centers for Disease Control and Prevention researchers will test one vaccine.
NIH doctors will also test ZMapp, an experimental drug, in Liberia and the U.S.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Ebola has killed 8,668 people, out of 21,759 infected worldwide, according to the World Health Organization.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.